Strengthening stakeholder engagement through ethics review in biomedicalHIVprevention trials: opportunities and complexities
Open Access
- 18 October 2018
- journal article
- review article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 21 (S7) , e25172
Abstract
Introduction: Clinical trials of biomedicalHIVprevention modalities require the cooperation of multiple stakeholders. Key stakeholders, such as community members, may have stark vulnerabilities. Consequently, calls forHIVprevention researchers to implement “stakeholder engagement” are increasingly common. Such engagement is held to benefit inter‐stakeholder relations, stakeholders themselves and the research itself. The ethics review process presents a unique opportunity to strengthen stakeholder engagement practices inHIVprevention trials. However, this is not necessarily straightforward. In this article, we consider several complexities. First, is stakeholder engagement a legitimate component of what Research Ethics Committees (RECs) should review forHIVprevention trials? Second, what are the core features of engagement that should be under ethics review? Third, what are the key practices that should be highlighted in ethics review?Methods: To address these questions, we examined the international ethics guidelines specialized for such trials (UNAIDS2012,UNAIDS‐AVAC GPP2011) and directly applicable to such trials (CIOMS2016;WHO2011). Thematic analysis was used to code and analyse these guidelines.Results and discussion: Ethics guidelines supportRECreview of engagement. Guidance recommends that engagement be broad and inclusive; early and sustained; and dynamic and responsive. Broad engagement practices include evaluating the context, planning in writing, and resourcing.RECs should assess engagement as part of a comprehensive review, and recommend revisions where necessary. Researchers should profile key elements of engagement valued in ethics guidance, when they draft ethics submissions. Importantly, the ethics review process should not undermine the ‘dynamic responsiveness’ required for excellent engagement in this field.Conclusions: As evidence‐informed engagement strategies emerge, these should inform the ethics submission and review process. Both parties in the review process should strive to avoid a superficial, check‐list type approach that caricatures what should be a thorough, nuanced ethics review of a rich, responsive engagement process.Keywords
Funding Information
- AIDS Relief (PEPFAR)
- US Agency for International Development (USAID)
This publication has 34 references indexed in Scilit:
- Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settingsTrials, 2018
- What Can IRBs Learn From CABs? A Qualitative Analysis of the Experiences of Recruitment and Training of Nonscientist Members on Research Review BoardsJournal of Empirical Research on Human Research Ethics, 2017
- Community engagement practices in Southern Africa: Review and thematic synthesis of studies done in Botswana, Zimbabwe and South AfricaActa Tropica, 2017
- Public/community engagement in health research with men who have sex with men in sub-Saharan Africa: challenges and opportunitiesHealth Research Policy and Systems, 2016
- Evaluating community engagement in global health research: the need for metricsBMC Medical Ethics, 2015
- Community engagement strategies for genomic studies in Africa: a review of the literatureBMC Medical Ethics, 2015
- Community engagement and the human infrastructure of global health researchBMC Medical Ethics, 2014
- A Systematic Review of the Empirical Literature Evaluating IRBs: What We Know and What We Still Need to LearnJournal of Empirical Research on Human Research Ethics, 2011
- Towards a framework for community engagement in global health researchTrends in Parasitology, 2010
- What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical ResearchThe Journal of Infectious Diseases, 2004